Please enjoy visiting our list of Collaborators. While SBH is not responsible for any of these third party sites, we feel the content they provide will be of interest to you.
PeproTech - www.peprotech.com
PeproTech is devoted to providing life science research with the highest
quality cytokine products. Over the past 20 years, PeproTech has successfully
been developing high yield, low cost methods for the commercial production of
over 300 recombinant cytokines, related antibodies and ELISA development kits.
Karyopharm - www.karyopharm.com
Karyopharm Therapeutics is a biopharmaceutical company focusing on the discovery and the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation.
SBH Sciences has collaborated with Karyopharm Therapeutics and we are contributing co-authors in their entire six scientific abstract.
Neumedicines Inc. - www.neumedicines.com
Neumedicines Inc. is exclusively engaged in research and development of both
prophylactics and therapeutics based on Interleukin-12 (IL-12) (HemaMax),
for the mitigation and reversal of radiological (myeloablative) and
myelosuppressive effects on the human hematopoietic system.
Improdia - www.improdia.co.il
Improdia's mission is to optimize personalized treatments of patients suffering from pathologies characterized by chronic inflammation. Improdia is developing a simple, rapid, reliable and non-invasive blood test for the evaluation of the individuals' immune status and inflammatory conditions based on revolutionary biomarkers, which sense the patients' immune system function.
Cell Assay Innovations - www.cellassayinnov.com
Cell Assay Innovations (CAI) is a biotechnology company dedicated to developing innovative cell-based assays for drug discovery. Their assay platform measures post-translational modifications of substrates, and is currently focused on kinases.
Woodland Pharmaceuticals - www.WoodlandPharmaceuticals.com
Woodland Pharmaceuticals LLC, is a preclinical contract research organization dedicated to advancing research through the innovative use of cancer cell lines and primary patient tumor samples. They provide complex animal modeling of PK/PD and efficacy studies, leading directly to to primary tumor models designed to improve clinical success.
SBH Diagnostics - www.SBHdiagnostics.com
SBH Diagnostics is a companion diagnostic company that is a joint-venture between SBH Sciences and GlycoZym, USA, focused on the commercialization of Laboratory Developed Tests mainly related to oncology, inflammation and neurological diseases. Combining the laboratory disciplines and expertise of SBH Sciences with the patented biomarker technology of GlycoZym, which is based on proprietary analysis of auto-antibodies, and their specific glycosylated target, we will be able to advance personalized medicine and provide better diagnostic tools under CLIA regulations. This approach will enable us to better develop new drugs (e.g. production of specific monoclonal antibodies).
Galectin Therapeutics - www.galectintherapeutics.com
Galectin Therapeutics is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company's unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function.
Procognia - www.procognia.com
Procognia (Israel) established in 2000, is a world leader in glycobiology and biopharmaceutical analytics. Procognia offers solutions to major challenges in biopharmaceutical and biosimilar development and manufacturing, including comprehensive analytical services for achievement of optimal glycosylation profiles for improved efficacy, safety and biosimilarity.
Oxford Biomedical Research - www.oxfordbiomed.com
Oxford Biomedical Research develops and markets specialty products for biomedical
research, primarily in the areas of oxidative stress, inflammation and eicosanoid metabolism, drug metabolism, signal transduction and
vascular biology. Oxford's extensive product line includes over 700 assay kits, antibodies and recombinant proteins.
Sanguine BioSciences - www.sanguinebio.com
Sanguine BioSciences provides highly viable (> %90) primary human cells and tissues
to the academic and industrial life science research community. The product offering
spans customers’ needs mainly in the In Vitro Research & Development stage of Drug
Development. Sanguine’s vision is to develop into the global leader in high quality
cells and tissues for life science research and development.
pION Inc. - www.pion-inc.com
pION Inc. is the world leader in permeability and solubility measurement.
They provide instruments and analytical services for ADME, solubility, permeability,
dissolution, pKa and log P determination.
Xtal BioStructures - www.xtalbiostructures.com
Xtal BioStructures provides structural biology contract services to small and
large pharmaceutical and biotechnology companies.
BioPAL - www.BioPAL.com
BioPhysics Assay Laboratory (BioPAL), Inc. provides the life science
community with products and methods to measure in vivo organ function and
to track compounds-of-interest in in-vivo systems. BioPAL offers products
that support seven different technology platforms: Neutron activation
technology (NA), Magnetic resonance imaging (MRI), Time resolved
fluorescent technology (TRF), Magnetic cell sorting technology (MCS),
Functional immunoassay technology (FIT), Molecular imaging and tracking
technology (MITT), and PET imaging and radiotherapy research (PET & Rad).